Cardiovascular-protective effect of tadalafil in the treatment of erectile dysfunction

Cialis is meant to affect your cardiovascular system. When you get an erection, the arteries in your penis relax and open up, allowing more blood flow in. At the same time, the veins in that area close up. Once blood is in the penis, the pressure traps it within your corpora cavernosa (a.k.a. your erectile tissue). This is what makes your penis expand.

[Cardiovascular-protective effect of tadalafil in the treatment of erectile dysfunction]

The enzyme phosphodiesterase-5 (PDE-5), widely distributed in the heart, smooth muscle, and blood vessels, catalyzes the hydrolysis of cyclic guanosine monophosphate (cGMP), a potent vasodilator, and is also a nitric oxide (NO) donor. Tadalafil is the first PDE 5 inhibitor approved by FDA for the treatment of ED. Recent studies have shown several pleiotropic beneficial effects of PDE-5 inhibitors in patients with cardiovascular diseases (coronary heart disease, hypertension, heart failure, and pulmonary arterial hypertension) and diabetes mellitus. It has been demonstrated that tadalafil can not only improve sexual function, but also elevate the endothelial cell-derived NO level, activate protein kinase A, upregulate the intracellular Ca2+ concentration, and improve hemodynamic indexes. Thus, the PDE-5 inhibitor tadalafil, with its cardiovascular-protective effect, can be a therapeutic option for the treatment of ED patients with cardiovascular disease.

Similar articles

Chrysant SG, Chrysant GS. Chrysant SG, et al. J Clin Hypertens (Greenwich). 2012 Sep;14(9):644-9. doi: 10.1111/j.1751-7176.2012.00669.x. Epub 2012 Jun 7. J Clin Hypertens (Greenwich). 2012. PMID: 22947364 Free PMC article. Review.

Ioakeimidis N, Kostis JB. Ioakeimidis N, et al. J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):53-64. doi: 10.1177/1074248413504034. Epub 2013 Nov 25. J Cardiovasc Pharmacol Ther. 2014. PMID: 24281316 Review.

Ravipati G, McClung JA, Aronow WS, Peterson SJ, Frishman WH. Ravipati G, et al. Cardiol Rev. 2007 Mar-Apr;15(2):76-86. doi: 10.1097/01.crd.0000233904.77128.49. Cardiol Rev. 2007. PMID: 17303994 Review.

Chrysant SG. Chrysant SG. Curr Hypertens Rep. 2013 Oct;15(5):475-83. doi: 10.1007/s11906-013-0377-9. Curr Hypertens Rep. 2013. PMID: 23917809 Review.

Liu KF. Liu KF. Zhonghua Nan Ke Xue. 2013 Sep;19(9):860-3. Zhonghua Nan Ke Xue. 2013. PMID: 24386867 Review. Chinese.